Pharmanutra S.p.A. (FRA:761)

Market Cap	561.79M
Revenue (ttm)	127.15M
Net Income (ttm)	17.45M
Shares Out	n/a
EPS (ttm)	1.82
PE Ratio	32.20
Forward PE	26.94
Dividend	1.00 (1.87%)
Ex-Dividend Date	May 5, 2025

Volume	n/a
Average Volume	10
Open	53.50
Previous Close	53.50
Day's Range	53.50 - 53.50
52-Week Range	38.55 - 57.90
Beta	n/a
RSI	69.31
Earnings Date	Mar 13, 2026

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and softwar...

• Industry: Pharmaceutical Preparations
• Founded: 2003
• Employees: 118
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 761

Financial Performance

In 2024, Pharmanutra's revenue was 116.15 million, an increase of 15.33% compared to the previous year's 100.71 million. Earnings were 16.61 million, an increase of 29.43%.